Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2021 Mar 26;11:7350. doi: 10.1038/s41598-021-86896-7

Author Correction: Therapeutic efficacy of repetitive transcranial magnetic stimulation in an animal model of Alzheimer’s disease

Jin Seung Choung 1, Jong Moon Kim 1,2, Myoung-Hwan Ko 3, Dong Sik Cho 4, MinYoung Kim 1,2,
PMCID: PMC7997913  PMID: 33772114

Correction to: Scientific Reports https://doi.org/10.1038/s41598-020-80147-x, published online 11 January 2021

This Article contains an error in Figue 4, where one of the labels is misspelled in panels (b) and (d).

‘Neun’

should read:

‘NeuN’

The correct Figure 4 appears below as Figure 1.

Figure 1.

Figure 1

A correct version of the original Figure 4. rTMS upregulates neurogenic expressions in AD mouse model. (a) Protein expression of hippocampal BDNF, Nestin and NeuN protein was measured by western blot. (b) Histograms show densitometry analysis of the western blot in hippocampus. (c) Protein expression of cortex BDNF, Nestin and NeuN protein was determined by the western blot. (d) Histograms show densitometry analysis of the western blot in cerebral cortex. Protein level of actin was analysed as a loading control. Mean data normalised to β-actin are in bar graphs compared with control. Each group n = 4, mean ± SEM.* Ps < 0.05. + Aβ42 oligomer injected via ICV, rTMS repetitive transcranial magnetic stimulation, AD Alzheimer’s Disease, BDNF brain-derived neurotrophic factor, Aβ42 amyloid beta 42 oligomer, None none treatment, High high frequency rTMS treated, Low low frequency rTMS treated, N.S. not significant.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES